Deregulated Myc Requires MondoA/Mlx for Metabolic Reprogramming and Tumorigenesis

Cancer Cell

Volumn 27, Issue 2, 2015, Pages 271-285

  Carroll, Patrick A ^a   Diolaiti, Daniel ^a   McFerrin, Lisa ^a   Gu, Haiwei ^b   Djukovic, Danijel ^b   Du, Jianhai ^c   Cheng, PeiFeng ^a   Anderson, Sarah ^a   Ulrich, Michelle ^a   Hurley, James B ^c   Raftery, Daniel ^a,b   Ayer, Donald E ^d   Eisenman, Robert N ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MILX PROTEIN; MYC PROTEIN; PEPTIDES AND PROTEINS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MONDOA; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; MONDOA PROTEIN, HUMAN; MYC PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL METABOLISM; CELL SURVIVAL; CITRIC ACID CYCLE; CONTROLLED STUDY; DIMERIZATION; GENE CONTROL; LIPOGENESIS; METABOLIC REPROGRAMMING; METABOLISM; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; CHEMISTRY; DRUG SCREENING; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; NEUROBLASTOMA; NUCLEAR REPROGRAMMING; PATHOLOGY; PROTEIN MULTIMERIZATION;

ANIMALS; APOPTOSIS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARCINOGENESIS; CELLULAR REPROGRAMMING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; NEUROBLASTOMA; PROTEIN MULTIMERIZATION; PROTO-ONCOGENE PROTEINS C-MYC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84922784813     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2014.11.024     Document Type: Article

References (64)

1. Basso K., Margolin A.A., Stolovitzky G., Klein U., Dalla-Favera R., Califano A. Reverse engineering of regulatory networks in human B cells. Nat. Genet. 2005, 37:382-390.
2. Billin A.N., Ayer D.E. The Mlx network: evidence for a parallel Max-like transcriptional network that regulates energy metabolism. Curr. Top. Microbiol. Immunol. 2006, 302:255-278.
3. Billin A.N., Eilers A.L., Queva C., Ayer D.E. Mlx, a novel Max-like BHLHZip protein that interacts with the Max network of transcription factors. J.Biol. Chem. 1999, 274:36344-36350.
4. Brodeur G.M. Neuroblastoma: biological insights into a clinical enigma. Nat. Rev. Cancer 2003, 3:203-216.
5. Conacci-Sorrell M., McFerrin L., Eisenman R.N. An overview of MYC and its interactome. Cold Spring Harb Perspect Med 2014, 4:a014357.
6. Dang C.V. Therapeutic targeting of Myc-reprogrammed cancer cell metabolism. Cold Spring Harb. Symp. Quant. Biol. 2011, 76:369-374.
7. Dang C.V. MYC on the path to cancer. Cell 2012, 149:22-35.
8. Dang C.V. MYC, metabolism, cell growth, and tumorigenesis. Cold Spring Harb Perspect Med 2013, 3:a014217.
9. Diolaiti D., McFerrin L., Carroll P.A., Eisenman R.N. Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis. Biochim. Biophys. Acta 2014.
10. Du P., Kibbe W.A., Lin S.M. lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008, 24:1547-1548.
11. Du J., Cleghorn W., Contreras L., Linton J.D., Chan G.C., Chertov A.O., Saheki T., Govindaraju V., Sadilek M., Satrústegui J., Hurley J.B. Cytosolic reducing power preserves glutamate in retina. Proc. Natl. Acad. Sci. USA 2013, 110:18501-18506.
12. Durán R.V., Oppliger W., Robitaille A.M., Heiserich L., Skendaj R., Gottlieb E., Hall M.N. Glutaminolysis activates Rag-mTORC1 signaling. Mol. Cell 2012, 47:349-358.
13. Eberlin L.S., Gabay M., Fan A.C., Gouw A.M., Tibshirani R.J., Felsher D.W., Zare R.N. Alteration of the lipid profile in lymphomas induced by MYC overexpression. Proc. Natl. Acad. Sci. USA 2014, 111:10450-10455.
14. Eischen C.M., Roussel M.F., Korsmeyer S.J., Cleveland J.L. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis. Mol. Cell. Biol. 2001, 21:7653-7662.
15. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 1998, 95:14863-14868.
16. Evan G.I., Wyllie A.H., Gilbert C.S., Littlewood T.D., Land H., Brooks M., Waters C.M., Penn L.Z., Hancock D.C. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992, 69:119-128.
17. Feng Z., Levine A.J. The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein. Trends Cell Biol. 2010, 20:427-434.
18. Gao P., Tchernyshyov I., Chang T.C., Lee Y.S., Kita K., Ochi T., Zeller K.I., De Marzo A.M., Van Eyk J.E., Mendell J.T., Dang C.V. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009, 458:762-765.
19. Griffiths B., Lewis C.A., Bensaad K., Ros S., Zhang Q., Ferber E.C., Konisti S., Peck B., Miess H., East P., et al. Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growth. Cancer Metab 2013, 1:3.
20. Han K.S., Ayer D.E. MondoA senses adenine nucleotides: transcriptional induction of thioredoxin-interacting protein. Biochem. J. 2013, 453:209-218.
21. Hooker C.W., Hurlin P.J. Of Myc and Mnt. J.Cell Sci. 2006, 119:208-216.
22. Huang M., Weiss W.A. Neuroblastoma and MYCN. Cold Spring Harb Perspect Med 2013, 3:a014415.
23. Huang W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
24. Hubert C.G., Bradley R.K., Ding Y., Toledo C.M., Herman J., Skutt-Kakaria K., Girard E.J., Davison J., Berndt J., Corrin P., et al. Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A. Genes Dev. 2013, 27:1032-1045.
25. Janoueix-Lerosey I., Lequin D., Brugières L., Ribeiro A., de Pontual L., Combaret V., Raynal V., Puisieux A., Schleiermacher G., Pierron G., et al. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature 2008, 455:967-970.
26. Kaadige M.R., Looper R.E., Kamalanaadhan S., Ayer D.E. Glutamine-dependent anapleurosis dictates glucose uptake and cell growth by regulating MondoA transcriptional activity. Proc. Natl. Acad. Sci. USA 2009, 106:14878-14883.
27. Kim S.S., Shago M., Kaustov L., Boutros P.C., Clendening J.W., Sheng Y., Trentin G.A., Barsyte-Lovejoy D., Mao D.Y., Kay R., et al. CUL7 is a novel antiapoptotic oncogene. Cancer Res. 2007, 67:9616-9622.
28. Leithner K., Hrzenjak A., Trötzmüller M., Moustafa T., Köfeler H.C., Wohlkoenig C., Stacher E., Lindenmann J., Harris A.L., Olschewski A., Olschewski H. PCK2 activation mediates an adaptive response to glucose depletion in lung cancer. Oncogene 2014, Published online March 17, 2014. 10.1038/onc.2014.47.
29. Li F., Wang Y., Zeller K.I., Potter J.J., Wonsey D.R., O'Donnell K.A., Kim J.W., Yustein J.T., Lee L.A., Dang C.V. Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol. Cell. Biol. 2005, 25:6225-6234.
30. Lin C.Y., Lovén J., Rahl P.B., Paranal R.M., Burge C.B., Bradner J.E., Lee T.I., Young R.A. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 2012, 151:56-67.
31. Link J.M., Ota S., Zhou Z.Q., Daniel C.J., Sears R.C., Hurlin P.J. A critical role for Mnt in Myc-driven T-cell proliferation and oncogenesis. Proc. Natl. Acad. Sci. USA 2012, 109:19685-19690.
32. Lopez-Bigas N., Cline M., Broom B., Margolin A., Omberg L., Weinstein J., Myles A. Thread 4: data discovery, transparency and visualization. Nat. Genet. 2013, Published online October 17, 2013. 10.1038/ng.2789.
33. Lutz W., Stöhr M., Schürmann J., Wenzel A., Löhr A., Schwab M. Conditional expression of N-myc in human neuroblastoma cells increases expression of alpha-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells. Oncogene 1996, 13:803-812.
34. McFerrin L.G., Atchley W.R. Evolution of the Max and Mlx networks in animals. Genome Biol. Evol. 2011, 3:915-937.
35. McFerrin L.G., Atchley W.R. A novel N-terminal domain may dictate the glucose response of Mondo proteins. PLoS ONE 2012, 7:e34803.
36. Méndez-Lucas A., Hyroššová P., Novellasdemunt L., Viñals F., Perales J.C. Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) is a pro-survival, endoplasmic reticulum (ER) stress response gene involved in tumor cell adaptation to nutrient availability. J.Biol. Chem. 2014, 289:22090-22102.
37. Meroni G., Cairo S., Merla G., Messali S., Brent R., Ballabio A., Reymond A. Mlx, a new Max-like bHLHZip family member: the center stage of a novel transcription factors regulatory pathway?. Oncogene 2000, 19:3266-3277.
38. Metallo C.M., Gameiro P.A., Bell E.L., Mattaini K.R., Yang J., Hiller K., Jewell C.M., Johnson Z.R., Irvine D.J., Guarente L., et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 2012, 481:380-384.
39. Morrish F., Noonan J., Perez-Olsen C., Gafken P.R., Fitzgibbon M., Kelleher J., VanGilst M., Hockenbery D. Myc-dependent mitochondrial generation of acetyl-CoA contributes to fatty acid biosynthesis and histone acetylation during cell cycle entry. J.Biol. Chem. 2010, 285:36267-36274.
40. Nicklin P., Bergman P., Zhang B., Triantafellow E., Wang H., Nyfeler B., Yang H., Hild M., Kung C., Wilson C., et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 2009, 136:521-534.
41. Nie Z., Hu G., Wei G., Cui K., Yamane A., Resch W., Wang R., Green D.R., Tessarollo L., Casellas R., et al. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 2012, 151:68-79.
42. O'Shea J.M., Ayer D.E. Coordination of nutrient availability and utilization by MAX- and MLX-centered transcription networks. Cold Spring Harb Perspect Med 2013, 3:a014258.
43. Oberthuer A., Berthold F., Warnat P., Hero B., Kahlert Y., Spitz R., Ernestus K., König R., Haas S., Eils R., et al. Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification. J.Clin. Oncol. 2006, 24:5070-5078.
44. Peterson C.W., Stoltzman C.A., Sighinolfi M.P., Han K.S., Ayer D.E. Glucose controls nuclear accumulation, promoter binding, and transcriptional activity of the MondoA-Mlx heterodimer. Mol. Cell. Biol. 2010, 30:2887-2895.
45. Qing G., Li B., Vu A., Skuli N., Walton Z.E., Liu X., Mayes P.A., Wise D.R., Thompson C.B., Maris J.M., et al. ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation. Cancer Cell 2012, 22:631-644.
46. Sans C.L., Satterwhite D.J., Stoltzman C.A., Breen K.T., Ayer D.E. MondoA-Mlx heterodimers are candidate sensors of cellular energy status: mitochondrial localization and direct regulation of glycolysis. Mol. Cell. Biol. 2006, 26:4863-4871.
47. Shachaf C.M., Perez O.D., Youssef S., Fan A.C., Elchuri S., Goldstein M.J., Shirer A.E., Sharpe O., Chen J., Mitchell D.J., et al. Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis. Blood 2007, 110:2674-2684.
48. Sloan E.J., Ayer D.E. Myc, mondo, and metabolism. Genes Cancer 2010, 1:587-596.
49. Sridharan R., Tchieu J., Mason M.J., Yachechko R., Kuoy E., Horvath S., Zhou Q., Plath K. Role of the murine reprogramming factors in the induction of pluripotency. Cell 2009, 136:364-377.
50. Stoltzman C.A., Peterson C.W., Breen K.T., Muoio D.M., Billin A.N., Ayer D.E. Glucose sensing by MondoA:Mlx complexes: a role for hexokinases and direct regulation of thioredoxin-interacting protein expression. Proc. Natl. Acad. Sci. USA 2008, 105:6912-6917.
51. Szabo C., Coletta C., Chao C., Módis K., Szczesny B., Papapetropoulos A., Hellmich M.R. Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer. Proc. Natl. Acad. Sci. USA 2013, 110:12474-12479.
52. Tong X., Zhao F., Mancuso A., Gruber J.J., Thompson C.B. The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation. Proc. Natl. Acad. Sci. USA 2009, 106:21660-21665.
53. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
54. Wang Q., Diskin S., Rappaport E., Attiyeh E., Mosse Y., Shue D., Seiser E., Jagannathan J., Shusterman S., Bansal M., et al. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Cancer Res. 2006, 66:6050-6062.
55. Wang H., Hammoudeh D.I., Follis A.V., Reese B.E., Lazo J.S., Metallo S.J., Prochownik E.V. Improved low molecular weight Myc-Max inhibitors. Mol. Cancer Ther. 2007, 6:2399-2408.
56. Wasylishen A.R., Kalkat M., Kim S.S., Pandyra A., Chan P.K., Oliveri S., Sedivy E., Konforte D., Bros C., Raught B., Penn L.Z. MYC activity is negatively regulated by a C-terminal lysine cluster. Oncogene 2014, 33:1066-1072.
57. Wernicke C.M., Richter G.H., Beinvogl B.C., Plehm S., Schlitter A.M., Bandapalli O.R., Prazeres da Costa O., Hattenhorst U.E., Volkmer I., Staege M.S., et al. MondoA is highly overexpressed in acute lymphoblastic leukemia cells and modulates their metabolism, differentiation and survival. Leuk. Res. 2012, 36:1185-1192.
58. Wise D.R., DeBerardinis R.J., Mancuso A., Sayed N., Zhang X.Y., Pfeiffer H.K., Nissim I., Daikhin E., Yudkoff M., McMahon S.B., Thompson C.B. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl. Acad. Sci. USA 2008, 105:18782-18787.
59. Xia J., Mandal R., Sinelnikov I.V., Broadhurst D., Wishart D.S. MetaboAnalyst 2.0-a comprehensive server for metabolomic data analysis. Nucleic Acids Res. 2012, 40:W127-W133.
60. Yuneva M., Zamboni N., Oefner P., Sachidanandam R., Lazebnik Y. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J.Cell Biol. 2007, 178:93-105.
61. Yuneva M.O., Fan T.W., Allen T.D., Higashi R.M., Ferraris D.V., Tsukamoto T., Matés J.M., Alonso F.J., Wang C., Seo Y., et al. The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab. 2012, 15:157-170.
62. Zaidi N., Lupien L., Kuemmerle N.B., Kinlaw W.B., Swinnen J.V., Smans K. Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids. Prog. Lipid Res. 2013, 52:585-589.
63. Zhang P., Metukuri M.R., Bindom S.M., Prochownik E.V., O'Doherty R.M., Scott D.K. c-Myc is required for the CHREBP-dependent activation of glucose-responsive genes. Mol. Endocrinol. 2010, 24:1274-1286.
64. Zhang J., Grubor V., Love C.L., Banerjee A., Richards K.L., Mieczkowski P.A., Dunphy C., Choi W., Au W.Y., Srivastava G., et al. Genetic heterogeneity of diffuse large B-cell lymphoma. Proc. Natl. Acad. Sci. USA 2013, 110:1398-1403.